Abstract
Changes in the interactions among the gut microbiota, intestinal epithelium, and host immune system are associated with many diseases, including cancer. We discuss how environmental factors influence this cross-talk during oncogenesis and tumor progression and how manipulations of the gut microbiota might improve the clinical activity of anticancer agents.
| Original language | English |
|---|---|
| Article number | 271ps1 |
| Journal | Science Translational Medicine |
| Volume | 7 |
| Issue number | 271 |
| DOIs | |
| State | Published - Jan 21 2015 |
| Externally published | Yes |